AMP-activated protein kinase as a therapeutic target: effects of nano-selenium and thymoquinone in Alzheimer's disease.

El-Sabbagh NA, Ellakwa DE

Open source

DOI
10.1080/13813455.2026.2640885
Published
2026 Aug
Container
Archives of physiology and biochemistry
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/13813455.2026.2640885,
  title = {AMP-activated protein kinase as a therapeutic target: effects of nano-selenium and thymoquinone in Alzheimer's disease.},
  author = {El-Sabbagh NA and Ellakwa DE},
  year = {2026},
  journal = {Archives of physiology and biochemistry},
  doi = {10.1080/13813455.2026.2640885},
  url = {https://doi.org/10.1080/13813455.2026.2640885}
}

RIS

TY  - JOUR
TI  - AMP-activated protein kinase as a therapeutic target: effects of nano-selenium and thymoquinone in Alzheimer's disease.
AU  - El-Sabbagh NA
AU  - Ellakwa DE
PY  - 2026
JO  - Archives of physiology and biochemistry
DO  - 10.1080/13813455.2026.2640885
UR  - https://doi.org/10.1080/13813455.2026.2640885
ER  - 

APA

NA, E., & DE, E. (2026). AMP-activated protein kinase as a therapeutic target: effects of nano-selenium and thymoquinone in Alzheimer's disease.. Archives of physiology and biochemistry. https://doi.org/10.1080/13813455.2026.2640885

Source records